Joanna Mangana Selected Research

Joanna Mangana Research Topics

Disease

43	Melanoma (Melanoma, Malignant) 02/2024 - 01/2009
12	Neoplasms (Cancer) 01/2021 - 09/2008
4	Disease Progression 11/2023 - 08/2018
4	Brain Neoplasms (Brain Tumor) 10/2021 - 01/2017
4	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2016
2	COVID-19 12/2022 - 01/2021
2	Colitis 01/2021 - 12/2019
2	Cytokine Release Syndrome 01/2019 - 01/2019
1	Skin Neoplasms (Skin Cancer) 05/2023
1	Infections 12/2022
1	Blindness (Hysterical Blindness) 01/2021
1	Uveitis 01/2021
1	Alopecia (Baldness) 01/2020
1	Extramammary Paget Disease (Paget Disease, Extramammary) 11/2019
1	Testicular Neoplasms (Testicular Cancer) 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 08/2018
1	Liver Diseases (Liver Disease) 08/2018
1	Sarcoidosis (Schaumann Disease) 01/2018
1	Uveal melanoma 01/2018
1	Acne Vulgaris 03/2017
1	Lymphoma (Lymphomas) 01/2017
1	Drug Eruptions (Drug Eruption) 01/2017
1	Hypoxia (Hypoxemia) 01/2016
1	Experimental Melanoma 01/2016
1	Hematologic Neoplasms (Hematological Malignancy) 01/2009
1	Hepatitis 01/2009

Drug/Important Bio-Agent (IBA)

11	Immune Checkpoint InhibitorsIBA 02/2024 - 01/2018
6	IpilimumabIBA 01/2022 - 01/2015
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2024 - 01/2018
5	NivolumabIBA 05/2023 - 01/2018
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2018
4	AntibodiesIBA 05/2023 - 01/2015
4	Proteins (Proteins, Gene)FDA Link 09/2020 - 01/2016
4	Phosphotransferases (Kinase)IBA 01/2019 - 04/2012
3	pembrolizumabIBA 05/2023 - 01/2021
2	Immunoglobulin G (IgG)IBA 01/2019 - 01/2019
2	AntigensIBA 01/2019 - 01/2018
2	Sorafenib (BAY 43-9006)FDA Link 08/2018 - 04/2012
2	InterferonsIBA 01/2018 - 01/2009
1	cyclopropapyrroloindoleIBA 01/2022
1	atezolizumabIBA 01/2021
1	Alanine Transaminase (SGPT)IBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	talimogene laherparepvecIBA 01/2021
1	Cyclin D1IBA 09/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2019
1	Trastuzumab (Herceptin)FDA Link 11/2019
1	Carboplatin (JM8)FDA LinkGeneric 11/2019
1	APTIBA 05/2019
1	Complement System Proteins (Complement)IBA 01/2019
1	Monophenol Monooxygenase (Tyrosinase)IBA 01/2019
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2019
1	MART-1 AntigenIBA 01/2019
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	ProteomeIBA 01/2019
1	Differentiation AntigensIBA 01/2019
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Methadone (Dolophine)FDA LinkGeneric 01/2018
1	Temozolomide (Temodar)FDA LinkGeneric 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	RetinoidsIBA 03/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2017
1	HMGB1 Protein (HMG1)IBA 01/2016
1	Interleukin-10 (Interleukin 10)IBA 01/2016
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 04/2012
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 04/2012
1	Dacarbazine (DIC)FDA LinkGeneric 04/2012
1	Interferon-alpha (Interferon Alfa)IBA 01/2009
1	CytokinesIBA 01/2009
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2008

Therapy/Procedure

27	Therapeutics 01/2024 - 01/2009
11	Immunotherapy 11/2023 - 01/2017
3	Drug Therapy (Chemotherapy) 12/2022 - 01/2017
2	Injections 12/2022 - 01/2021
2	Aftercare (After-Treatment) 01/2021 - 01/2018
1	Salvage Therapy 11/2023
1	Palliative Care (Palliative Therapy) 12/2022
1	Critical Care (Surgical Intensive Care) 01/2021
1	Radiotherapy 12/2020
1	Liver Transplantation 08/2018
1	Lasers (Laser) 05/2010
1	Laser Therapy (Surgery, Laser) 05/2010